Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Rang in Aktien
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Aktienkurs
$3.40
Marktkapitalisierung
$9.07B
Veränderung (1 Tag)
-1.61%
Veränderung (1 Jahr)
-16.08%
Land
CN
Handel Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Anzahl der ausstehenden Aktien zum October 2026: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Shanghai Fosun Pharmaceutical (Group) Co., Ltd. beträgt die aktuelle Anzahl der ausstehenden Aktien 0. Am Ende von October 2026 hatte das Unternehmen 0 ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) von 2001 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2025 | 2.65B | -0.64% |
| 2024 | 2.66B | -0.67% |
| 2023 | 2.68B | 2.83% |
| 2022 | 2.61B | 1.74% |
| 2021 | 2.56B | 0.00% |
| 2020 | 2.56B | 0.00% |
| 2019 | 2.56B | 1.60% |
| 2018 | 2.52B | 2.55% |
| 2017 | 2.46B | 6.08% |
| 2016 | 2.32B | 0.86% |
| 2015 | 2.30B | 0.11% |
| 2014 | 2.30B | 3.03% |
| 2013 | 2.23B | 14.02% |
| 2012 | 1.95B | 2.31% |
| 2011 | 1.91B | 1.77% |
| 2010 | 1.88B | 1.46% |
| 2009 | 1.85B | 0.00% |
| 2008 | 1.85B | 0.54% |
| 2007 | 1.84B | 8.49% |
| 2006 | 1.70B | -3.52% |
| 2005 | 1.76B | 0.00% |
| 2004 | 1.76B | 0.00% |
| 2003 | 1.76B | 0.00% |
| 2002 | 1.76B | 0.00% |
| 2001 | 1.76B | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
